We are delighted to welcome Longboat Energy CEO Helge Hammer and BD Director Nick Ingrassia #LBE to Tuesday’s live webinar. They join Atlantic Lithium CEO Vincent Mascolo #ALL #IRR, Cora Gold CEO Bert Monro #CORA and Valirx CEO Suzanne Dilly #VAL. Please register here

Less Ads, More Data, More Tools Register for FREE

Italy to resume use of AstraZeneca jab from Friday - PM Draghi

Thu, 18th Mar 2021 17:16

ROME, March 18 (Reuters) - Italy will resume using the
AstraZeneca COVID-19 vaccine from Friday, Prime Minister Mario
Draghi said, following a report by the European Medicines Agency
which judged that its benefits outweighed risks.

Italy was among a dozen countries that had suspended the use
of the vaccine earlier this week after reports of rare blood
disorders in a handful of people who had recently received a
jab.

"The government's priority remains to vaccinate as many
people as possible as quickly as possible," Draghi said in a
brief statement.
(Reporting By Gavin Jones, editing by Crispian Balmer)

Related Shares

More News

Two Hutchmed drugs included in China's 2022 reimbursement list

(Sharecast News) - Hutchmed China announced on Friday that, following negotiations with the China National Healthcare Security Administration (NHSA), from 1 January the updated National Reimbursement Drug List (NRDL) will continue to include 'Elunate', or fruquintinib, and would now include 'Sulanda', or surufatinib.

3 Dec 21 13:23

Omicron cases outside South Africa no deadlier, Australian official says

(Sharecast News) - On current evidence, the Omicron variant of Covid-19 did not yet appear to be any deadlier than previous ones, Australian health officials said.

2 Dec 21 08:40

All confirmed Omicron cases in EU thus far are asymptomatic or have shown mild symptoms

(Sharecast News) - All confirmed cases of the Omicron variant of concern detected thus far in the European Union had thus far had been either asymptomatic or shown "mild" symptoms, the bloc's pandemic watchdog said.

30 Nov 21 21:49

AstraZeneca cancer drug Lynparza is granted priority review in US

AstraZeneca cancer drug Lynparza is granted priority review in US

30 Nov 21 09:52

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.